LifeStance Health Net Profit Margin 2020-2023 | LFST

LifeStance Health net profit margin from 2020 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
LifeStance Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2023-12-31 $1.06B $-0.19B -17.60%
2023-09-30 $1.01B $-0.19B -18.71%
2023-06-30 $0.96B $-0.16B -17.08%
2023-03-31 $0.91B $-0.19B -20.66%
2022-12-31 $0.86B $-0.22B -25.12%
2022-09-30 $0.82B $-0.28B -33.74%
2022-06-30 $0.78B $-0.36B -46.20%
2022-03-31 $0.73B $-0.36B -49.45%
2021-12-31 $0.67B $-0.34B -51.35%
2021-09-30 $0.60B $-0.24B -40.27%
2021-06-30 $0.52B $-0.12B -23.47%
2021-03-31 $0.45B $-0.09B -19.02%
2020-12-31 $0.38B $-0.04B -10.08%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.668B $1.056B
LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.425B 10.54
Quest Diagnostics (DGX) United States $15.213B 15.72
DaVita (DVA) United States $12.075B 15.00
Chemed (CHE) United States $8.786B 27.23
Encompass Health (EHC) United States $8.647B 22.13
Elanco Animal Health (ELAN) United States $6.680B 15.19
Option Care Health (OPCH) United States $5.270B 19.95
RadNet (RDNT) United States $3.877B 104.94
Amedisys (AMED) United States $3.018B 21.38
Astrana Health (ASTH) United States $2.125B 28.74
Addus HomeCare (ADUS) United States $1.712B 24.49
U.S Physical Therapy (USPH) United States $1.591B 42.58
Pennant (PNTG) United States $0.628B 33.19
Aveanna Healthcare Holdings (AVAH) United States $0.454B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00